A prospective, single-center, randomized phase 2 trial of etoposide in severe COVID-19 https://www.medrxiv.org/content/10.1101/2023.06.05.23290969
A prospective, single-center, randomized phase 2 trial of etoposide in severe COVID-19 https://www.medrxiv.org/content/10.1101/2023.06.05.23290969